IDEAS home Printed from https://ideas.repec.org/a/inm/orinte/v28y1998i3p3-22.html
   My bibliography  Save this article

OR Modeling and AIDS Policy: From Theory to Practice

Author

Listed:
  • James G. Kahn

    (Center for AIDS Prevention Studies, Institute for Health Policy Studies, University of California, San Francisco, San Francisco, California 94143)

  • Margaret L. Brandeau

    (Department of Industrial Engineering and Engineering Management, Stanford University, Stanford, California 94305)

  • John Dunn-Mortimer

    (Consultant on Health Care Systems and Government Affairs, 715 Laurel Avenue, #201, San Mateo, California 94401)

Abstract

The AIDS epidemic is a serious, growing public health problem worldwide, but resources for treating HIV-infected patients and for combating the spread of the virus are limited. Governments, public-health agencies, and health-care providers must determine how best to allocate scarce resources for HIV treatment and prevention among different programs and populations. OR-based models have influenced—and can influence—AIDS policy decisions. Mathematical modeling has had an effect on AIDS policy in a number of areas, including estimating HIV prevalence and incidence in the United States, understanding the pathophysiology of HIV, evaluating costs and benefits of HIV-screening programs, evaluating the effects of needle-exchange programs, and determining policies for HIV/AIDS care in California. Further work is needed to model a range of programs using comparable methods, to model overall epidemic control strategy, and to improve the usefulness of OR-based models for policy making.

Suggested Citation

  • James G. Kahn & Margaret L. Brandeau & John Dunn-Mortimer, 1998. "OR Modeling and AIDS Policy: From Theory to Practice," Interfaces, INFORMS, vol. 28(3), pages 3-22, June.
    • Handle: RePEc:inm:orinte:v:28:y:1998:i:3:p:3-22
    DOI: 10.1287/inte.28.3.3
    as

    Download full text from publisher

    File URL: http://dx.doi.org/10.1287/inte.28.3.3
    Download Restriction: no
    File URL: https://libkey.io/10.1287/inte.28.3.3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Kahn, J.G., 1996. "The cost-effectiveness of HIV prevention targeting: How much more bang for the buck?," American Journal of Public Health, American Public Health Association, vol. 86(12), pages 1709-1712.
    2. Margaret L. Brandeau & Douglas K. Owens & Carol H. Sox & Robert M. Wachter, 1993. "Screening Women of Childbearing Age for Human Immunodeficiency Virus: A Model-Based Policy Analysis," Management Science, INFORMS, vol. 39(1), pages 72-92, January.
    3. Siegel, J.E. & Weinstein, M.C. & Fineberg, H.V., 1991. "Bleach programs for preventing AIDS among IV drug users: Modeling the impact of HIV prevalence," American Journal of Public Health, American Public Health Association, vol. 81(10), pages 1273-1279.
    4. E. Rizakou & J. Rosenhead & K. Reddington, 1991. "AIDSPLAN: A Decision Support Model for Planning the Provision of HIV/AIDS-Related Services," Interfaces, INFORMS, vol. 21(3), pages 117-129, June.
    5. Julie A. Scharfstein & A. David Paltiel & Kenneth A. Freedberg, 1997. "The Cost-Effectiveness of Fluconazole Prophylaxis against Primary Systemic Fungal Infections in AIDS Patients," Medical Decision Making, , vol. 17(4), pages 373-381, October.
    6. Donna M. Edwards & Ross D. Shachter & Douglas K. Owens, 1998. "A Dynamic HIV-Transmission Model for Evaluating the Costs and Benefits of Vaccine Programs," Interfaces, INFORMS, vol. 28(3), pages 144-166, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Richter, Anke & Hicks, Katherine A. & Earnshaw, Stephanie R. & Honeycutt, Amanda A., 2008. "Allocating HIV prevention resources: A tool for state and local decision making," Health Policy, Elsevier, vol. 87(3), pages 342-349, September.
    2. Stephen E. Chick & Sada Soorapanth & James S. Koopman, 2003. "Inferring Infection Transmission Parameters That Influence Water Treatment Decisions," Management Science, INFORMS, vol. 49(7), pages 920-935, July.
    3. Jing Yao & Alan T. Murray, 2014. "Locational Effectiveness of Clinics Providing Sexual and Reproductive Health Services to Women in Rural Mozambique," International Regional Science Review, , vol. 37(2), pages 172-193, April.
    4. David W. Hutton & Margaret L. Brandeau & Samuel K. So, 2011. "Doing Good with Good OR: Supporting Cost-Effective Hepatitis B Interventions," Interfaces, INFORMS, vol. 41(3), pages 289-300, June.
    5. Lasry, Arielle & Zaric, Gregory S. & Carter, Michael W., 2007. "Multi-level resource allocation for HIV prevention: A model for developing countries," European Journal of Operational Research, Elsevier, vol. 180(2), pages 786-799, July.
    6. Sarang Deo & Kumar Rajaram & Sandeep Rath & Uday S. Karmarkar & Matthew B. Goetz, 2015. "Planning for HIV Screening, Testing, and Care at the Veterans Health Administration," Operations Research, INFORMS, vol. 63(2), pages 287-304, April.
    7. Margaret L. Brandeau, 2016. "Creating impact with operations research in health: making room for practice in academia," Health Care Management Science, Springer, vol. 19(4), pages 305-312, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Lasry, Arielle & Zaric, Gregory S. & Carter, Michael W., 2007. "Multi-level resource allocation for HIV prevention: A model for developing countries," European Journal of Operational Research, Elsevier, vol. 180(2), pages 786-799, July.
    2. Gregory S. Zaric & Margaret L. Brandeau & Paul G. Barnett, 2000. "Methadone Maintenance and HIV Prevention: A Cost-Effectiveness Analysis," Management Science, INFORMS, vol. 46(8), pages 1013-1031, August.
    3. Robalino, David A. & Jenkins, Carol & El Maroufi, Karim, 2002. "Risks and macroeconomic impacts of HIV/AIDS in the Middle East and North Africa : why waiting to intervene can be costly," Policy Research Working Paper Series 2874, The World Bank.
    4. Martin A. Andresen & Ehsan Jozaghi, 2012. "The Point of Diminishing Returns: An Examination of Expanding Vancouver’s Insite," Urban Studies, Urban Studies Journal Limited, vol. 49(16), pages 3531-3544, December.
    5. Stephanie R. Earnshaw & Anke Richter & Stephen W. Sorensen & Thomas J. Hoerger & Katherine A. Hicks & Michael Engelgau & Ted Thompson & K. M. Venkat Narayan & David F. Williamson & Edward Gregg & Ping, 2002. "Optimal Allocation of Resources across Four Interventions for Type 2 Diabetes," Medical Decision Making, , vol. 22(1_suppl), pages 80-91, September.
    6. Brandeau, Margaret L. & Zaric, Gregory S. & Richter, Anke, 2003. "Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis," Journal of Health Economics, Elsevier, vol. 22(4), pages 575-598, July.
    7. Romain Micol & Ayden Tajahmady & Olivier Lortholary & Suna Balkan & Catherine Quillet & Jean-Philippe Dousset & Hak Chanroeun & Yoann Madec & Arnaud Fontanet & Yazdan Yazdanpanah, 2010. "Cost-Effectiveness of Primary Prophylaxis of AIDS Associated Cryptococcosis in Cambodia," PLOS ONE, Public Library of Science, vol. 5(11), pages 1-8, November.
    8. Gregory S. Zaric & Margaret L. Brandeau, 2001. "Optimal Investment in a Portfolio of HIV Prevention Programs," Medical Decision Making, , vol. 21(5), pages 391-408, October.
    9. Edward H. Kaplan, 1999. "Implicit Valuation of a Blood-exclusion Decision," Medical Decision Making, , vol. 19(2), pages 207-213, April.
    10. M S Rauner & S C Brailsford & S Flessa, 2005. "Use of discrete-event simulation to evaluate strategies for the prevention of mother-to-child transmission of HIV in developing countries," Journal of the Operational Research Society, Palgrave Macmillan;The OR Society, vol. 56(2), pages 222-233, February.
    11. Zheng Zhang & Brian T. Denton & Todd M. Morgan, 2022. "Optimization of active surveillance strategies for heterogeneous patients with prostate cancer," Production and Operations Management, Production and Operations Management Society, vol. 31(11), pages 4021-4037, November.
    12. Steven D. Pinkerton & Harrell W. Chesson & David R. Holtgrave & William Kassler & Peter M. Layde, 2000. "When is an HIV Infection Prevented and when is it Merely Delayed?," Evaluation Review, , vol. 24(3), pages 251-271, June.
    13. Jingyu Zhang & Brian T. Denton & Hari Balasubramanian & Nilay D. Shah & Brant A. Inman, 2012. "Optimization of Prostate Biopsy Referral Decisions," Manufacturing & Service Operations Management, INFORMS, vol. 14(4), pages 529-547, October.
    14. Postma, Maarten J. & Jager, Johannes C. & Dijgraaf, Marcel G. W. & Borleffs, Jan C. C. & Tolley, Keith & Leidl, Reiner M., 1995. "AIDS scenarios for The Netherlands; the economic impact on hospitals," Health Policy, Elsevier, vol. 31(2), pages 127-150, February.
    15. Negar Darabi & Niyousha Hosseinichimeh, 2020. "System dynamics modeling in health and medicine: a systematic literature review," System Dynamics Review, System Dynamics Society, vol. 36(1), pages 29-73, January.
    16. Duijzer, Lotty Evertje & van Jaarsveld, Willem & Dekker, Rommert, 2018. "Literature review: The vaccine supply chain," European Journal of Operational Research, Elsevier, vol. 268(1), pages 174-192.
    17. Douglas K. Owens & Margaret L. Brandeau & Carol H. Sox, 1998. "Effect of Relapse to High-Risk Behavior on the Costs and Benefits of a Program to Screen Women for Human Immunodeficiency Virus," Interfaces, INFORMS, vol. 28(3), pages 52-74, June.
    18. Joseph N Jarvis & Thomas S Harrison & Stephen D Lawn & Graeme Meintjes & Robin Wood & Susan Cleary, 2013. "Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa," PLOS ONE, Public Library of Science, vol. 8(7), pages 1-9, July.
    19. Gregory S. Zaric, 2003. "The Impact of Ignoring Population Heterogeneity when Markov Models are Used in Cost-Effectiveness Analysis," Medical Decision Making, , vol. 23(5), pages 379-386, September.
    20. Wilson, Amy R. & Kahn, James G. & Oren, Shmuel S., 2005. "Targeting interventions to high-risk populations: Benefits and costs," Socio-Economic Planning Sciences, Elsevier, vol. 39(4), pages 335-349, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:inm:orinte:v:28:y:1998:i:3:p:3-22. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Asher (email available below). General contact details of provider: https://edirc.repec.org/data/inforea.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.